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Introduction
More than 1.5 million cancers are diagnosed each year in the United States.1 This 
Dartmouth Atlas report examines how elderly patients with poor prognosis cancer 
are cared for across regions and hospitals and finds remarkable variation depending 
on where the patients live and receive care. Even among the nation’s leading medi-
cal centers, there is no consistent pattern of care or evidence that treatment patterns 
follow patient preferences. Rather, the report demonstrates that many hospitals and 
physicians aggressively treat patients with curative attempts they may not want, at 
the expense of improving the quality of their last weeks and months.
For many cancer patients, medical and surgical care leads to long-term remission or 
cure. Other patients have aggressive or disseminated (metastatic) cancer at the time 
of diagnosis or experience a recurrence later in their illness. Despite achievements 
in cancer detection and treatment, half a million patients die of cancer annually in the 
United States. The majority of these deaths are in those over age 65.2
For patients with a poor prognosis because the cancer is advanced or disseminated, 
death is the likely short-term outcome. When a cure is unlikely, patients and families 
often have strong preferences about where and how they are cared for in their last 
months of life. Some desire aggressive treatment up to the time of death. These 
patients seek to gain weeks or months of additional life irrespective of treatment 
side effects and the isolation from home and family that aggressive treatment often 
entails. Other patients with limited life expectancy prefer care directed toward the 
quality rather than the quantity of life. They want to be able to bring closure to their 
lives with a focus on their comfort in familiar surroundings, close to family and friends. 
They also want control of pain and the many other difficult symptoms associated with 
advanced cancer and its aggressive treatment.3
Patients with cancer also want honest conversations with their providers. This 
includes balanced information about the chances of disease remission or progres-
sion, and the possible benefits and discomforts of different treatment options. Most 
importantly, they want to be active partners with clinicians in making the decisions 
about the type and place of care.
Too often, care for patients near the end of life falls short of the desires of patients 
and families. This has been well documented for patients with advanced illness and 
specifically for cancer. The Institute of Medicine’s 1997 report, “Approaching Death: 
Improving Care at the End of Life,” documented the pervasive undertreatment of pain 
and other burdensome symptoms, as well as overtreatment with curative measures 
that many patients do not want.4 In 2001, the Institute released a related report, 
“Improving Palliative Care for Cancer,” which concluded: 
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Improvements in the development and delivery of symptom control and other 
aspects of palliative care needed in the late stages of cancer (and other chron-
ic diseases) have not kept pace with the medical advances that have allowed 
people to live longer. For at least half of those dying from cancer, death entails 
a spectrum of symptoms, including pain, labored breathing, distress, nausea, 
confusion, and other physical and psychological conditions that go untreated or 
undertreated and vastly diminish the quality of their remaining days. Patients, 
their families, and caregivers all suffer from the inadequate care available to 
patients in pain and distress, although the magnitude of these burdens is only 
now being described.5
In the past decade, the cancer care community has developed a heightened inter-
est in improving palliative and hospice care for patients with advanced cancer.6-10 
Numerous performance measures on the quality of cancer care have been devel-
oped; several of these are specifically for care near the end of life.11-15
In this report the Dartmouth Atlas Project examines care for Medicare patients over 
age 65 with cancers that have a poor prognosis and finds that care at the end of life 
varies markedly across regions and academic medical centers. The major findings 
are as follows:
1. Across many regions and academic medical centers, over one third of patients 
with poor prognosis cancer spent their last days in hospitals and intensive care 
units. A significant proportion of patients received advanced life support inter-
ventions such as endotracheal intubation, feeding tubes and cardiopulmonary 
resuscitation (CPR).
2. The use of chemotherapy in the last two weeks of life overall was about 
6% of patients, but in some regions and academic medical centers the rate 
exceeded 10%.
3. The use of hospice care varied markedly across regions and hospitals. In at 
least 50 academic medical centers, less than half of patients with poor progno-
sis cancer received hospice services.
4. In some hospitals, referral to hospice care occurred so close to the day of 
death that it was unlikely to have provided much assistance and comfort to 
patients.
Do these patterns of care reflect patient and family preferences? While this report 
does not measure patient treatment choices directly, published research strongly indi-
cates that care patterns near the end of life are partly driven by the local availability 
of health resources, such as hospital beds and new treatment technologies.16,17 In 
addition, communication with cancer patients and families often fails to include accu-
rate information about prognosis and treatment options.18 These studies suggest 
that high hospital day rates and low hospice use are often signs of overly aggressive 
treatment. While many health systems have addressed some of these shortcomings, 
further work needs to be done to improve end-of-life care. The findings presented in 
this report provide a starting point for the longitudinal monitoring of further efforts to 
improve care for patients with poor prognosis cancer.
Data for the care of Medicare 
patients with poor prognosis 
cancer are available for all hos-
pitals with sufficiently large study 
populations, as well as hospital 
referral regions, on our web 
site: www.dartmouthatlas.org. 
Excel tables are available on our 
Downloads page; or you can cre-
ate your own reports using our 
custom report tools. To get start-
ed, click on Data by Topic, then 
select Care of Chronic Illness 
in Last Two Years of Life. In the 
Start a Report menu, select the 
Cancer Care topic, and choose a 
measure to explore.
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Hospital use in patients with poor prognosis 
cancer
Most patients with serious illness prefer to be at home at the end of life, in familiar 
settings and close to family. A smaller number of patients want to receive life-sus-
taining care, even if it means spending more time in the hospital for treatments 
accompanied by serious adverse effects and debilitating symptoms.19 These dif-
ferences in patient preferences are often a challenge for clinicians to incorporate in 
care decisions when cure or remission is the hope of nearly every patient with can-
cer. The well-documented failure in counseling patients about their prognosis and 
the full range of care options, including early palliative care, leads many patients 
to acquiesce to more aggressive care without fully understanding its impact on the 
length and quality of life.
Regional variation in hospital care
We observed a high degree of regional variation in the amount of inpatient care 
patients with poor prognosis cancer received. The known differences in racial and 
ethnic preferences for aggressive treatment at the end of life are not large enough to 
explain the degree of variation we observed19; nor can it be explained by differences 
in patient illness levels. These were all patients known to their health care teams to 
have advanced or disseminated cancer. The differences in the amount of hospital 
care received by these patients can help identify regions and hospitals where there 
are opportunities to improve the quality of the patient decision process.
A Report of the Dartmouth Atlas Project
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Death in the hospital among hospital referral regions
Across the United States, about 29% of cancer patients who died during the period 
from 2003 to 2007 did so in a hospital. Cancer patients were most likely to die in a 
hospital in the Manhattan hospital referral region, where 46.7% experienced death 
in a hospital. The rates were also high in surrounding regions, including Ridgewood, 
New Jersey (42.8%), East Long Island, New York (42.5%) and Newark, New Jer-
sey (41.1%). These rates were about six times higher than the rate in the Mason 
City, Iowa region, where only 7.0% of cancer patients died in the hospital. Cancer 
patients were also much less likely to experience a hospitalized death in Cincinnati 
(17.8%) and Fort Lauderdale, Florida (19.6%).
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Figure 1. Percent of cancer patients dying 
in hospital among hospital referral regions 
(deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. The percent of cancer patients dying in 
a hospital ranged from 7% in Mason City, Iowa to 
almost 47% in Manhattan.
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Map 1. Percent of cancer patients dying in hospital (deaths 
occurring 2003-07)
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Hospital admissions during the last month of life 
among hospital referral regions
The percent of cancer patients hospitalized at least once during their last month 
of life varied by a factor of about 1.6 during the period from 2003 to 2007. Cancer 
patients were most likely to be hospitalized during the last month of life in hospital 
referral regions in Michigan, including Detroit (70.2%), Royal Oak (69.4%), Pon-
tiac (69.4%) and Dearborn (69.1%). Rates were also high in the southernmost 
Texas regions of McAllen (69.3%) and Harlingen (69.2%). Less than half of cancer 
patients were hospitalized during the last month of life in Mason City, Iowa (44.9%), 
San Angelo, Texas (46.3%), Cedar Rapids, Iowa (48.0%) and La Crosse, Wiscon-
sin (49.0%). Nationally, 61.3% of cancer patients were hospitalized at least once 
during their last month of life.
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Figure 2. Percent of cancer patients 
hospitalized during the last month of life 
among hospital referral regions (deaths 
occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. Less than half of cancer patients were 
admitted to a hospital in the last month of life in five 
regions, while nearly 70% of cancer patients were 
admitted in other regions.
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Map 2. Percent of cancer patients hospitalized during the 
last month of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Hospital days during the last month of life among 
hospital referral regions
On average, cancer patients spent 5.1 days in the hospital during the last month of 
life. Cancer patients spent a week or more of their last month of life in the hospital 
in several regions in New York and New Jersey, including Manhattan (7.3 days), 
Newark (7.1), Ridgewood, New Jersey (7.1) and New Brunswick, New Jersey (7.0). 
Patients spent four or fewer days in the hospital during the last month of life in Salt 
Lake City (3.5), Madison, Wisconsin (3.7) and Portland, Oregon (4.0).
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Figure 3. Average number of days spent 
in hospital per cancer patient during the 
last month of life among hospital referral 
regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. The amount of time cancer patients spent in 
the hospital during the last month of life varied more 
than twofold, from 2.7 days in Mason City, Iowa to 
more than a week in Manhattan.
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Map 3. Average number of days spent in hospital per 
cancer patient during the last month of life (deaths 
occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Intensive care admissions during the last month of life 
among hospital referral regions
About 24% of cancer patients were admitted to intensive care at least once dur-
ing their last month of life. However, the percent admitted to intensive care varied 
more than sevenfold across hospital referral regions. More than 40% of cancer 
patients who died from 2003 to 2007 were admitted to intensive care during the last 
month of life in Huntsville, Alabama (42.4%), McAllen, Texas (41.0%), Los Angeles 
(40.3%) and Miami (40.3%). Only 6% of cancer patients were admitted to intensive 
care during the last month of life in Mason City, Iowa. Admission rates to intensive 
care were also low in Madison, Wisconsin (13.0%), Portland, Maine (14.3%) and 
Minneapolis (14.6%).
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Figure 4. Percent of cancer patients 
admitted to intensive care during the 
last month of life among hospital referral 
regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. Seven times more cancer patients were 
admitted to intensive care during the last month of 
life in the Huntsville, Alabama region than in Mason 
City, Iowa.
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Map 4. Percent of cancer patients admitted to intensive care 
during the last month of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Intensive care days during the last month of life among 
hospital referral regions
The average number of days cancer patients spent in intensive care units during 
the last month of life varied dramatically across hospital referral regions. Intensive 
care days per patient in the highest regions, including Huntsville, Alabama (3.1 
days), Miami (3.0) and McAllen, Texas (2.8) were more than 25 times higher than 
the number of days in the lowest regions, Mason City, Iowa (0.1) and Appleton, 
Wisconsin (0.1). Intensive care days were also low in Minneapolis (0.4), Portland, 
Oregon (0.5) and Albany, New York (0.7). The national average of days spent in 
intensive care per cancer patient during the last month of life was 1.3.
Figure 5. Average number of days spent in 
intensive care per cancer patient during the 
last month of life among hospital referral 
regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. On average, cancer patients spent 1.3 days in 
intensive care during the last month of life, but this rate 
varied by a factor of more than 25 across regions.
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Map 5. Average number of days spent in intensive care 
per cancer patient during the last month of life (deaths 
occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Variation in hospital care across academic 
medical centers
Academic medical centers in the U.S. are at the forefront of patient care, medical 
education and research. Most of the new knowledge about cancer care has been 
developed at academic medical centers, including those designated as National 
Cancer Institute Cancer Centers. These health systems aspire to practice at the 
highest level of evidence-based care for cancer treatment. There have been few 
previous studies of end-of-life care at academic medical centers,20 particularly of 
cancer care. This report provides information about the care provided to Medicare 
beneficiaries at specific centers for several indicators of end-of-life care quality, 
beginning with the use of hospital care.
There is a remarkable amount of variation in the use of hospitals for elderly patients 
with poor prognosis cancer who are near the end of life. Even after controlling for 
cancer type, age, sex and race, there were more than twofold differences in the 
number of days spent in hospitals and intensive care units in the last month of 
life. These differences in patient care should stimulate teaching hospitals to further 
examine clinician practice styles and decision-making processes in relation to the 
evolving national norms of quality end-of-life care.
What should hospitals do to improve care 
for patients at the end of life? 
Fundamental to patient-centered cancer care are health 
care providers educating patients about their progno-
ses, eliciting their preferred treatment approaches, and 
formulating care plans that respect their choices regard-
ing the goals of care. The majority of cancer patients 
want to be involved in their medical care, but a collusion 
of silence and health care fragmentation results in far 
too many patients uninformed of their prognoses and 
the option of hospice. Many are informed far too late, 
resulting in hospice referral in the last three days of life. 
This pattern of care often leaves the dying patient in 
pain and without the opportunity to say “goodbye, I love 
you, please carry on…” 
So what should hospitals and academic medical 
centers do? Be leaders and embrace patient- and fam-
ily-centered care for all patients, especially those with 
cancers with poor prognoses. Hospitals should examine 
their rates of ICU utilization, hospice referral, and oth-
er utilization measures and then ask: do these results 
reflect a practice of educating patients about their prog-
noses, eliciting their choices, and forming care plans 
that respect patients’ goals of care? If opportunities to 
improve are identified, hospitals should work with the 
local hospice or existing palliative care consult ser-
vice, and/or start a palliative care consult service, to 
ensure that the institution is delivering high-quality care. 
Health care reform presents an important opportunity 
to restructure health care and transition from serving 
the needs of institutions to providing care that focuses 
on patients, as well as the family members and friends 
who care for them.
Joan M. Teno, MD, MS is a Professor of Community 
Health and Medicine at the Warren Alpert School of 
Medicine of Brown University and Associate Medical 
Director of Home and Hospice Care of Rhode Island.
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The percent of cancer patients dying in a hospital varied threefold 
among patients receiving most of their care at academic medical cen-
ters (Figure 6). More than half of cancer patients died in the hospital 
among those receiving care at New York Methodist Hospital (54.9%) 
and Maimonides Medical Center (54.3%), both in Brooklyn. Other 
New York City hospitals had much lower rates of death in hospital 
among cancer patients, including St. Vincent’s Hospital (now closed) 
in Manhattan (30.4%) and Montefiore Medical Center in the Bronx 
(32.1%); however, even these rates were more than 60% higher than 
the rate at the lowest academic medical center, Evanston Northwest-
ern Healthcare (18.7%).
The likelihood of being admitted to the hospital during the last month of 
life among cancer patients varied from less than 50% to more than 75% 
across academic medical centers (Figure 7). The percent of cancer 
patients hospitalized during the last month of life was highest among 
patients frequenting two Detroit hospitals, St. John Hospital and Medi-
cal Center (78.1%) and Sinai-Grace Hospital (75.3%). Less than half 
of cancer patients were admitted to the hospital during the last month 
of life among those using the University of Washington Medical Center 
in Seattle (44.6%), the University of Iowa Hospitals and Clinics in Iowa 
City (48.1%) and the H. Lee Moffitt Cancer Center in Tampa, Florida 
(49.9%).
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Figure 6. Percent of cancer patients dying 
in hospital among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. The percent of cancer patients dying in the 
hospital ranged from 18.7% of patients using Evanston 
Northwestern Healthcare in Evanston, Illinois, to 
57.3% of patients using Westchester Medical Center 
in Valhalla, New York.
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Figure 7. Percent of cancer patients 
hospitalized during the last month of life 
among patients receiving most of their 
care at academic medical centers (deaths 
occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. The percent of cancer patients hospitalized 
during the last month of life varied by a factor of 1.75 
from the lowest to the highest hospital.
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On average, cancer patients using several New York and New Jer-
sey hospitals spent a week or more in the hospital during their last 
month of life. These hospitals included Newark Beth Israel Medi-
cal Center (8.7 days), Westchester Medical Center in Valhalla, 
New York (8.7), New York Methodist Hospital in Brooklyn (8.6) and 
Winthrop-University Hospital in Mineola, New York (8.5). Patients at 
Albany Medical Center, by contrast, spent an average of 4.5 days 
in the hospital during the last month of life. Among New York City 
hospitals, the day rate per patient during the last month of life was 
lowest at Memorial Sloan-Kettering Cancer Center (6.3).
The percent of cancer patients admitted to intensive care dur-
ing the last month of life varied fivefold among those frequenting 
academic medical centers. Nearly half of cancer patients were 
admitted to intensive care during the last month of life at St. John 
Hospital and Medical Center in Detroit (46.1%) and Allegheny 
General Hospital in Pittsburgh (46.0%). Use of intensive care units 
for cancer patients was dramatically lower at Memorial Sloan-Ket-
tering Cancer Center in Manhattan (8.9%) and Montefiore Medical 
Center in the Bronx (12.1%).
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Figure 8. Average number of days spent in 
hospital per cancer patient during the last 
month of life among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. Cancer patients using the University of 
California Davis Medical Center in Sacramento spent 
3.7 days in the hospital during the last month of life; 
cancer patients using Newark Beth Israel Medical 
Center spent more than twice this amount of time in 
the hospital.
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Figure 9. Percent of cancer patients 
admitted to intensive care during the last 
month of life among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. Cancer patients were more than five times 
more likely to be admitted to intensive care during 
the last month of life at Cooper Health System in 
Camden, New Jersey than at Memorial Sloan-
Kettering Cancer Center: the rates at these hospitals 
were 49.2% and 8.9%, respectively.
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The average number of days cancer patients spent in intensive care during the last 
month of life varied by a factor of nearly 15. Intensive care day rates were among 
the highest for cancer patients using three hospitals in Pennsylvania: Allegheny 
General Hospital in Pittsburgh (4.1 days), Thomas Jefferson University Hospital in 
Philadelphia (3.3) and Lankenau Hospital in Wynnewood (3.2). By contrast, inten-
sive care day rates among cancer patients were among the lowest at Geisinger 
Medical Center in Danville, Pennsylvania (0.5).
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Figure 10. Average number of days spent in 
intensive care per cancer patient during the 
last month of life among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. Cancer patients spent, on average, 0.3 days in 
intensive care during the last month of life at St. Francis 
Hospital and Medical Center in Hartford, Connecticut 
and Fletcher Allen Health Care in Burlington, Vermont. 
The rate was nearly 15 times higher at Allegheny 
General Hospital.
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Hospital days in the last month of life are a 
good indicator of care intensity across regions
The hospital where a patient with advanced cancer received care determined 
more than the number of days they spent in the hospital. Patients with more hos-
pital days also spent more days in intensive care units, received more aggressive 
treatment—such as endotracheal intubation, feeding tube placement, CPR and 
chemotherapy—and received care from many different physicians. Figures 11 to 
14 show that, across hospital referral regions, there was a positive association 
between the number of hospital inpatient days experienced by patients during the 
last month of life and other types of cancer care.i
R2 = 0.33
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Figure 11. The relationship between 
the average number of days spent in 
hospital and in intensive care per cancer 
patient during the last month of life 
among hospital referral regions (deaths 
occurring 2003-07)
The figure shows the relationship between the 
average number of days cancer patients spent 
in the hospital and in intensive care during the 
last month of life. Each dot represents one of 306 
hospital referral regions. One third of the variation in 
the ICU day rate can be explained by the variation 
in the hospital day rate (R2 = 0.33).
Hospital days per patient during the last month of life
IC
U 
da
ys
 p
er
 p
at
ie
nt
 d
ur
in
g 
th
e 
la
st
 m
on
th
 o
f l
ife
R2 = 0.44
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Figure 12. The relationship between the 
average number of days spent in hospital 
per cancer patient and the percent of 
cancer patients receiving life-sustaining 
treatment during the last month of life 
among hospital referral regions (deaths 
occurring 2003-07)
The figure shows the relationship between the 
average number of days cancer patients spent in 
hospital and the percent receiving life-sustaining 
treatment during the last month of life among hospital 
referral regions. There was a strong relationship 
between the amount of time cancer patients spent 
in the hospital and their likelihood of receiving a life-
sustaining procedure (R2 = 0.44).
Hospital days per patient during the last month of life
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i  The R2 value is an indication of the strength of the correlation between two variables. For example, if the R2 association 
between the number of days cancer patients spent in the hospital during the last month of life and the percent receiv-
ing chemotherapy during the last two weeks if life was 0.07, that means that only 7% of the variation in the percent of 
patients receiving chemotherapy could be explained by the hospital day rate. That is a weak relationship. An R2 of 0.50, 
on the other hand, would suggest that the average number of hospital days per cancer patient accounted for 50% of the 
variation in the percent receiving chemotherapy. That is a strong relationship.
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R2 = 0.34
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Figure 13. The relationship between the 
average number of days spent in hospital 
per cancer patient during the last month 
of life and the percent of cancer patients 
seeing ten or more physicians during the 
last six months of life among hospital 
referral regions (deaths occurring 2003-07)
Among hospital referral regions, the variation in the 
number of days cancer patients spent in the hospital 
during their last month of life explained 34% of the 
variation in the percent seeing ten or more different 
physicians during the last six months of life (R2 = 0.34).
Hospital days per patient during the last month of life
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Figure 14. The relationship between the 
average number of days spent in hospital 
per cancer patient during the last month 
of life and the percent of cancer patients 
receiving chemotherapy during the last 
two weeks of life among hospital referral 
regions (deaths occurring 2003-07)
The relationship between the amount of time cancer 
patients spent in the hospital during their last month 
of life and the likelihood of receiving chemotherapy 
during their last two weeks of life was negligible among 
hospital referral regions (R2 = 0.07).
Hospital days per patient during the last month of life
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Hospital days in the last month of life are 
not always a good indicator of care intensity 
across academic medical centers
Although more hospital days in the last month of life correlated with more aggres-
sive cancer care at a regional level, this was not always true for individual hospitals. 
Figures 15 to 18 show a relatively weak relationship between the number of hos-
pital days in the last month of life and other types of cancer care among patients 
receiving their care at academic medical centers. This reflects the differences in the 
ways that specific academic medical centers care for patients with poor prognosis 
cancer. For example in some hospitals where patients generally received more 
hospital days of care, patients spent no more time in the ICU, but received a greater 
number of chemotherapy treatments.
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Figure 15. The relationship between the 
average number of days spent in hospital 
and in intensive care per cancer patient 
during the last month of life among 
patients receiving most of their care 
at academic medical centers (deaths 
occurring 2003-07)
The figure shows the relationship between the 
average number of days cancer patients spent in 
the hospital and in intensive care during the last 
month of life among patients using 137 academic 
medical centers most often for their care. There was 
a weak relationship between the overall amount of 
time spent in the hospital and time spent in intensive 
care (R2 = 0.09).
Hospital days per patient during the last month of life
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Figure 16. The relationship between the 
average number of days spent in hospital 
per cancer patient and the percent of 
cancer patients receiving life-sustaining 
treatment during the last month of life 
among patients receiving most of their 
care at academic medical centers (deaths 
occurring 2003-07)
There was a relatively strong relationship between 
the amount of time spent in the hospital and the 
likelihood of experiencing a life-sustaining procedure 
among cancer patients frequently using academic 
medical centers (R2 = 0.33).
Hospital days per patient during the last month of life
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R2 = 0.39
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Figure 18. The relationship between the 
average number of days spent in hospital 
per cancer patient during the last month 
of life and the percent of cancer patients 
receiving chemotherapy during the last 
two weeks of life among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
There was a moderate relationship between the 
amount of time cancer patients spent in the hospital 
during their last month of life and their likelihood of 
receiving chemotherapy during their last two weeks 
of life among patients frequenting academic medical 
centers (R2 = 0.15).
Figure 17. The relationship between 
the average number of days spent in 
hospital per cancer patient during the 
last month of life and the percent of 
cancer patients seeing ten or more 
physicians during the last six months 
of life among patients receiving most of 
their care at academic medical centers 
(deaths occurring 2003-07)
Almost 40% of the variation in the percent of cancer 
patients seeing ten or more different physicians 
during the last six months of life among academic 
medical centers can be explained by the number of 
days cancer patients spent in the hospital during 
their last month of life (R2 = 0.39).
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Variation in cancer care directed toward cure 
at the end of life
Chemotherapy and life-sustaining procedures can prolong life and return some 
cancer patients to home and work. For frail elderly patients, and any patient with 
advanced cancer, these treatments have limited or no benefit. Across hospital 
referral regions and academic medical centers, there is marked variation in the 
frequency of these types of aggressive treatment.
Atul Gawande, a surgeon at Brigham and Women’s Hospital in Boston, has 
written about the challenges faced by patients and physicians as the end of life 
nears. His article “Letting go: What should medicine do when it can’t save your 
life?” was published in The New Yorker on August 2, 2010 and can be found at 
www.newyorker.com/reporting/2010/08/02/100802fa_fact_gawande
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Life-sustaining treatments
This section presents three treatments associated with 
aggressive end-of-life care: endotracheal intubation, 
feeding tube placement and cardiopulmonary resusci-
tation (CPR).
Endotracheal intubation. Endotracheal intubation is 
the insertion of a special breathing tube through the 
mouth into the windpipe to provide oxygen and breath-
ing assistance with a mechanical ventilator. Patients 
usually need to be sedated as long as they have this 
breathing tube, and even mildly sedated patients are 
unable to talk to caregivers and family. These patients 
require careful monitoring and nursing care and usually 
remain in intensive care units. This can be a life-saving 
procedure for patients who need temporary assistance 
with breathing. Patients near the end of life, such as poor 
prognosis cancer patients, are rarely able to breathe 
again on their own. While some hours or days of life 
may be gained, patients are often unaware of their sur-
roundings and unable to communicate with family and 
caregivers.
Feeding tube placement. One way of providing water 
and nutrition for very ill patients who cannot eat by 
mouth is to insert a tube through the skin and muscles 
of the abdomen and into the stomach. The tube can be 
left in place for weeks or months. Fluids are then slowly 
pumped into the stomach. The feeding tube placement 
procedure is done by a surgeon with the patient under 
heavy sedation or anesthesia. This can help some 
patients get better sooner by improving their nutritional 
state. For patients near the end of life, a feeding tube 
has few benefits and means being attached to a feeding 
pump for many hours of the day.
Cardiopulmonary resuscitation. When a patient’s 
lungs or heart stops, CPR attempts to prevent immedi-
ate death by compressing the chest and pumping air 
into the lungs through the mouth. For some causes of 
cardiopulmonary arrest, CPR is lifesaving, although 
only a small proportion of patients recover enough to 
leave the hospital. However, an extremely small num-
ber of patients with terminal cancer can be successfully 
resuscitated. Many elderly patients suffer injury during 
the resuscitation process, including broken ribs. For 
patients who want to die peacefully with family close 
by, CPR is very disruptive. It is extremely rare that CPR 
succeeds in prolonging life in a way that allows patients 
to communicate again with spouses and relatives.
These procedures can save lives and provide good 
long-term outcomes for many patients with serious ill-
ness, including pneumonia, early stage cancer, or 
a heart attack. However, in patients with advanced 
chronic illness, particularly poor prognosis cancer, the 
likelihood that life will be prolonged is very low. Each of 
the procedures has the potential for causing harm or 
prolonging suffering. Patients who are included in the 
decision-making process about their end-of-life care, 
either before or when they are ill, often decline these 
procedures.
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Chemotherapy during the last two weeks of life
The percent of cancer patients receiving chemotherapy during their last two weeks 
of life varied fourfold among hospital referral regions. More than 10% of cancer 
patients received chemotherapy during this period in eight regions, including Olym-
pia, Washington (12.6%) and San Antonio, Texas (10.8%). About 3% of cancer 
patients received chemotherapy during the last two weeks of life in Worcester, 
Massachusetts and Baton Rouge, Louisiana. On average, 6% of cancer patients 
received chemotherapy during the last two weeks of life across the United States.
The variation was similar among patients receiving most of their care at academic 
medical centers. More than 10% of cancer patients received chemotherapy during 
the last two weeks of life at four hospitals, including Lenox Hill Hospital in Manhattan 
(12.2%) and Cedars-Sinai Medical Center in Los Angeles (11.5%). Less than 4% 
had chemotherapy at the Cleveland Clinic (2.9%), Johns Hopkins Hospital (3.8%) 
and the University of Pittsburgh’s Presbyterian Shadyside Medical Center (3.9%).
Figure 19. Percent of cancer patients 
receiving chemotherapy during the last 
two weeks of life among hospital referral 
regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. Nearly 13% of cancer patients received 
chemotherapy during the last two weeks of life in 
Olympia, Washington and Minot, North Dakota. About 
3% of cancer patients experienced this treatment in 
five regions.
Figure 20. Percent of cancer patients 
receiving chemotherapy during the last two 
weeks of life among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 51 academic medical 
centers with a sufficient number of patients receiving 
chemotherapy during the last two weeks of life to report 
the measure. The rates varied fourfold, from about 3% 
of cancer patients to about 12%.
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Map 6. Percent of cancer patients receiving chemotherapy 
during the last two weeks of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Life-sustaining treatment during the last month of life
Among cancer patients, the percent receiving life-sustaining treatment during the 
last month of life was about 9%, but rates varied by a factor of more than six among 
hospital referral regions. Cancer patients were most likely to receive life-sustaining 
treatment in the Manhattan hospital referral region, where 18.2% experienced a 
procedure such as endotracheal intubation, feeding tube placement or CPR. Rates 
of life-sustaining treatment were also high in Los Angeles (17.5%), Orange County, 
California (16.7%) and Chicago (16.2%). Cancer patients were much less likely 
to experience aggressive life-sustaining procedures in Minneapolis (3.9%), Des 
Moines (5.1%) and Seattle (6.4%).
Rates of aggressive life-sustaining treatment during the last month of life varied 
more than fivefold among cancer patients using academic medical centers. More 
than 20% of cancer patients experienced life-sustaining treatment during the last 
month of life at six hospitals, including three in the New York metropolitan area: 
New York Methodist Hospital (26.7%), Maimonides Medical Center (22.9%) and 
Lenox Hill Hospital (20.8%). Rates were below 10% at 34 hospitals, including the 
University of Texas M.D. Anderson Cancer Center (6.6%), Massachusetts General 
Hospital (6.7%) and Memorial Sloan-Kettering Cancer Center (8.2%).
Figure 21. Percent of cancer patients 
receiving life-sustaining treatment during 
the last month of life among hospital 
referral regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. The percent of cancer patients receiving a life-
sustaining procedure varied more than sixfold among 
regions, from less than 3% in Green Bay, Wisconsin to 
more than 18% in Manhattan.
Figure 22. Percent of cancer patients 
receiving life-sustaining treatment 
during the last month of life among 
patients receiving most of their care 
at academic medical centers (deaths 
occurring 2003-07)
Each dot represents one of 114 academic medical 
centers with a sufficient number of cancer patients 
receiving life-sustaining procedures during the 
last month of life to report the measure. The rates 
varied more than fivefold, from less than 5% of 
cancer patients at Maine Medical Center to about 
27% at New York Methodist Hospital.
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Map 7. Percent of cancer patients receiving life-sustaining 
treatment during the last month of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Variation in hospice care at the end of life
For elderly patients with serious illness and a life expectancy of six 
months or less, Medicare benefits include hospice services. Hospice 
care is directed toward comfort and support services that allow patients 
to live out their lives to the fullest extent possible.21 Whenever possible, 
care is provided in the home, and includes palliative services to control 
symptoms, home care services, and family support prior to and after 
the death of the patient. Patients choose to enroll in hospice, and they 
may withdraw from hospice care at any time.
Hospice care has gained increasing recognition as a valuable way to 
improve the quality of life for patients with poor prognosis cancer. Still, 
in many places, the fight for a cancer cure or remission can crowd out 
discussions with patients about the full range of available treatments, 
including palliative and hospice care. There was a marked degree of 
variation in the percent of cancer patients who died and received hos-
pice care in the last month of life. This variation was high across both 
hospital referral regions and academic medical centers.
Percent enrolled in hospice during the last 
month of life
Nationally, about 55% of cancer patients who died during the period 
from 2003 to 2007 used hospice services during their last month of 
life. However, cancer patients in some regions were more than three 
times more likely to be enrolled in hospice during the last month of life 
than patients in others. In Mason City, Iowa, 82.5% of cancer patients 
were enrolled in hospice during the last month of life. More than three 
quarters of cancer patients also used hospice services in Sun City, Ari-
zona (79.9%) and Fort Myers, Florida (75.6%). By contrast, less than 
one quarter of cancer patients used hospice in the last month of life in 
the Bronx (21.0%) and Anchorage, Alaska (24.4%). Rates were also 
relatively low in Manhattan (31.3%) and Los Angeles (39.9%).
Use of hospice services during the last month of life among cancer 
patients frequenting academic medical centers also varied nearly four-
fold. More than 70% of cancer patients were enrolled in hospice during 
the last month of life among those receiving care at Monmouth Medical 
Center in Long Branch, New Jersey (73.0%), Evanston Northwestern 
Healthcare in Evanston, Illinois (72.1%) and the University Hospitals 
of Cleveland (70.6%). Less than 20% of cancer patients used hospice 
services during the last month of life at Westchester Medical Center 
in Valhalla, New York (18.6%) and Montefiore Medical Center in the 
Bronx (18.6%).
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Figure 24. Percent of cancer patients 
enrolled in hospice during the last month 
of life among patients receiving most of 
their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. About 20% of cancer patients used hospice 
services during the last month of life at three 
hospitals; more than 70% of cancer patients used 
hospice during this period at four hospitals.
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Figure 23. Percent of cancer patients 
enrolled in hospice during the last month of 
life among hospital referral regions (deaths 
occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. Use of hospice services by cancer patients 
during the last month of life varied nearly fourfold, 
from about 20% to more than 80%.
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Map 8. Percent of cancer patients enrolled in hospice during 
the last month of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Hospice days during the last month of life
On average, cancer patients dying between 2003 and 2007 spent 8.7 days in hos-
pice during the last month of life. In some hospital referral regions, cancer patients 
spent almost half of their last month of life in hospice, including Mason City, Iowa 
(14.4 days), Dothan Alabama (13.6) and San Angelo, Texas (13.3). Cancer patients 
spent less than one week in hospice in the Bronx (3.9 days), Los Angeles (5.8) and 
San Francisco (6.6).
Among cancer patients using academic medical centers for most of their care, the 
amount of time spent in hospice during the last month of life varied more than four-
fold. Patients spent more than 12 days in hospice at the University Medical Center 
in Lubbock, Texas (12.8) and the University of Iowa Hospitals and Clinics (12.5). By 
contrast, cancer patients spent less than four days in hospice at four New York City-
area hospitals, including Montefiore Medical Center (2.7), Westchester Medical 
Center (2.8), New York Methodist Hospital (3.6) and New York-Presbyterian Hospi-
tal (3.8). The number of days spent in hospice was closer to the national average at 
St. Luke’s-Roosevelt Hospital Center in New York City (7.8).
Figure 25. Average number of days in 
hospice per cancer patient during the 
last month of life among hospital referral 
regions (deaths occurring 2003-07)
Each dot represents one of 306 hospital referral 
regions. The amount of time spent in hospice varied 
more than threefold, from less than four days per 
cancer patient during the last month of life to more 
than two weeks.
Figure 26. Average number of days in 
hospice per cancer patient during the last 
month of life among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. The amount of time cancer patients spent in 
hospice during the last month of life varied from 2.7 
days at the lowest-ranked academic medical center 
to 12.8 days at the highest.
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Map 9. Average number of days in hospice per cancer patient 
during the last month of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Variation in less effective hospice care
The goal of helping cancer patients live out their last weeks and months with as 
much comfort and function as possible cannot be achieved if patients enter hospice 
care just before they die. Of course no one can predict with certainty when a patient 
with serious illness will pass away, but in some health care systems, a relatively 
high proportion of cancer patients do not enter hospice until they are within three 
days of death. These regions and academic medical centers may have important 
opportunities to improve the care of patients with poor prognosis cancer.
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Dying well – things for us all to consider
Remarkable advances in cancer science have cured countless people who 
would have died prematurely in earlier times. Additionally, millions of Americans 
now live for years with treatable cancers. Still, today, cancer claims too many 
lives. No one likes to think about themselves or someone they love dying. Yet in 
the course of incurable cancer, there often comes a time at which more treat-
ment does not equal better care. Instead, comfort and quality of life become 
paramount.
At the end of a courageous fight against a relentless disease, the vast majority 
of people want to die gently. Few people want to be in a hospital in their final 
days; fewer still want to die in an ICU, tethered to drips and devices. Most of us 
would like to be at home, or in a homelike setting, surrounded by people we love 
and that love us. These are reasonable goals, but planning and preparation are 
required to reliably achieve them.
As a doctor caring for people who have serious, life-threatening conditions, I 
commonly ask patients to consider a few basic questions: What is most impor-
tant to you as you think about the end of your life? Where would you like to be 
during your final days? Who would you want to care for you? What types of treat-
ment would you want, or not want?
It is important for each of us to discuss our personal answers to these questions 
with our families and our doctors. It is also important for each of us to complete 
an advance directive that formally names those we trust to speak for us in mak-
ing health care decisions if we become unable to speak for ourselves. 
For people who want to be at home through the end of life, and for families who 
want to care for them, hospice is essential. Hospice programs provide medica-
tions needed to control pain and other discomfort, visits by highly skilled nurses, 
a team of professionals, and quick access to someone to answer questions or 
manage problems 24 hours a day. 
Please talk with your family and the people you love about these difficult but 
important matters. It is also worthwhile to consider if there would be anything left 
unsaid if you—or they—were to die suddenly, as any of us might. Because we 
are all mortal, it is never too soon to say Please forgive me, I forgive you, Thank 
you, I love you. In so doing, we will be better able to live fully and, when the time 
comes, better prepared to say Goodbye. 
Ira Byock, MD is Director of Palliative Care at Dartmouth-Hitchcock Medical 
Center and a professor at Dartmouth Medical School. He is the author of Dying 
Well and The Four Things That Matter Most.
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Percent enrolled in hospice during the last 
three days of life
The percent of cancer patients enrolled in hospice during the last 
three days of life varied sixfold among hospital referral regions. The 
likelihood of being enrolled in hospice at the very end of life was great-
er than 15% in five regions, including Royal Oak, Michigan (18.0%), 
Sun City, Arizona (17.7%) and Fort Lauderdale, Florida (15.8%). Less 
than 4% of patients were admitted to hospice in the last three days of 
life in Tupelo, Mississippi (3.0%) and Anchorage (3.7%). The national 
average was 8.3%. In general, the use of hospice during the last three 
days of life reflected the overall use of hospice during the last month 
of life in individual regions. However, this was not always the case; for 
example, in the Dothan, Alabama region, a relatively high percentage 
of cancer patients received hospice services during the last month of 
life (68.7%), but only 5.1% of cancer patients were enrolled in the last 
three days of life.
The likelihood of being enrolled in hospice in the last three days of 
life among cancer patients using academic medical centers varied 
more than fivefold during the period from 2003 to 2007, from less than 
4% to almost 20%. The percent of cancer patients enrolled in hos-
pice within three days of death was high among those using St. John 
Hospital and Medical Center in Detroit (19.3%), St. Mary’s Health 
Center in Richmond Heights, Missouri (17.3%) and Mercy Hospital of 
Pittsburgh (14.0%). Less than 5% of cancer patients were enrolled in 
hospice during the last three days of life at Memorial Sloan-Kettering 
Cancer Center (3.4%) and New York-Presbyterian Hospital (4.1%), 
reflecting relatively low use of hospice among cancer patients fre-
quenting those hospitals. The rate was also low at Duke University 
Hospital (4.9%).
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Figure 27. Percent of cancer patients 
enrolled in hospice during the last three 
days of life among hospital referral regions 
(deaths occurring 2003-07)
Each dot represents one of 306 hospital referral regions. 
The percent of cancer patients enrolled in hospice at the 
very end of life ranged from 3% to 18%.
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Figure 28. Percent of cancer patients 
enrolled in hospice during the last three 
days of life among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 84 academic medical 
centers with a sufficient number of cancer patients 
enrolled in hospice during the last three days of life to 
report the measure. Rates varied by a factor of more 
than five, from 3.4% to 19.3%.
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Map 10. Percent of cancer patients enrolled in hospice during 
the last three days of life (deaths occurring 2003-07)
A Report of the Dartmouth Atlas Project
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Hospice care and curative care
Elderly patients with hospice care generally receive much less hospital-based care. 
This is in keeping with the goals and reimbursement requirements of the Medicare 
hospice program. Regions and hospitals with patients receiving higher amounts of 
hospice care, on average, were much less likely to have patients die in the hospital, 
and the patients spent fewer days in the hospital in the last month of life. There was 
not a strong relationship between more hospice days and fewer ICU days, life-sus-
taining procedures or chemotherapy treatments. Overall, these associations show 
that patients cared for at hospitals providing higher amounts of hospice services did 
not consistently receive less intensive and curative care.
R2 = 0.51
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Figure 29. The relationship between the 
average number of hospice days per 
cancer patient during the last month of life 
and the percent of cancer patients dying 
in hospital among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. There was a strong negative relationship 
between the amount of time cancer patients spent 
in hospice care and the percent dying in a hospital 
(R2 = 0.51).
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Pe
rc
en
t o
f d
ea
th
s 
oc
cu
rr
in
g 
in
 h
os
pi
ta
l
R2 = 0.49
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
2.0 4.0 6.0 8.0 10.0 12.0 14.0
Figure 30. The relationship between the 
average number of hospice days and 
hospital days per cancer patient during the 
last month of life among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. In general, the more time cancer patients 
spent in hospice during the last month of life, the 
less time they spent as inpatients in hospitals, as 
demonstrated by the strong negative association 
between the two measures (R2 = 0.49).
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H
os
pi
ta
l d
ay
s 
pe
r p
at
ie
nt
 d
ur
in
g 
th
e 
la
st
 m
on
th
 o
f l
ife
a rEPort of tHE dartMoutH atlas ProJECt  37 
Hospice days per patient during the last month of life
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R2 = 0.00
Figure 31. The relationship between the 
average number of hospice days and 
intensive care days per cancer patient 
during the last month of life among 
patients receiving most of their care 
at academic medical centers (deaths 
occurring 2003-07)
Each dot represents one of 137 academic medical 
centers. There was no relationship between the 
amount of time cancer patients spent in hospice 
and in intensive care during the last month of life 
(R2 = 0.00).
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R2 = 0.21
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Figure 32. The relationship between 
the average number of hospice days 
per cancer patient and the percent of 
cancer patients receiving life-sustaining 
treatment during the last month of 
life among patients receiving most of 
their care at academic medical centers 
(deaths occurring 2003-07)
There was a moderate negative relationship 
between the amount of time spent in hospice care 
and the likelihood of receiving a life-sustaining 
procedure during the last month of life (R2 = 0.21) 
among the 114 academic medical centers with a 
sufficient number of cancer patients receiving life-
sustaining procedures during the last month of life 
to report the measure.
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R2 = 0.13
Figure 33. The relationship between the average number of 
hospice days per cancer patient and the percent of cancer patients 
receiving chemotherapy during the last two weeks of life among 
patients receiving most of their care at academic medical centers 
(deaths occurring 2003-07)
Each dot represents one of 51 academic medical centers with a sufficient number 
of patients receiving chemotherapy during the last two weeks of life to report the 
measure. The association between the amount of time spent in hospice and the 
likelihood of receiving chemotherapy during the last two weeks of life was slightly 
negative (R2 = 0.13).Pe
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Cancer care as a reflection of the broader 
patterns of end-of-life care
Medicare beneficiaries with serious cancer are usually cared for by highly spe-
cialized clinical teams. The care they provide, however, is often reflective of more 
general patterns of care received by patients with chronic illness. In other words, 
the style of care provided to cancer patients near the end of life is very similar to 
the care given to patients at the same hospital who die with other types of chronic 
disease, such as congestive heart failure, diabetes, dementia or chronic obstructive 
pulmonary disease.
Figures 34 to 37 show that there were strong associations in care patterns for 
patients who died with cancer and those who died with chronic illness in general. 
These associations were observed for the percent dying in the hospital, the number 
of hospital and ICU days, and the number of hospice days. The improvement of 
care for cancer patients may be accelerated by the recognition that care patterns 
often cut across many different patient types and care teams within a hospital.
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Figure 34. The relationship between the 
percent of cancer patients and the percent 
of all chronically ill patients dying in 
hospital among patients receiving most 
of their care at academic medical centers 
(deaths occurring 2003-07)
The relationship between the percent of cancer 
patients and all chronically ill patients dying in a 
hospital was very strong among patients receiving 
most of their care at academic medical centers 
(R2 = 0.73). In other words, 73% of the variation in 
rates of death in hospital among cancer patients 
was explained by the variation among all patients 
with one of nine serious chronic illnesses (including 
cancer).
Percent of chronically ill 
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Figure 35. The relationship between the 
average number of days spent in hospital 
among cancer patients (last month of life) 
and all chronically ill patients (last six 
months of life) among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
More than half of the variation in the average 
number of days cancer patients spent in the 
hospital during the last month of life was explained 
by the overall amount of time chronically ill patients 
spent in the hospital during the last six months of 
life (R2 = 0.53).
Hospital days per chronically ill patient 
during the last six months of life
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R2 = 0.64
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Figure 36. The relationship between the 
average number of days spent in intensive 
care among cancer patients (last month of 
life) and all chronically ill patients (last six 
months of life) among patients receiving 
most of their care at academic medical 
centers (deaths occurring 2003-07)
Nearly two thirds of the variation in the amount of 
time cancer patients spent in intensive care during 
the last month of life was explained by the variation 
in the amount of time chronically ill patients spent 
in intensive care during the last six months of life in 
general (R2 = 0.64).
ICU days per chronically ill patient 
during the last six months of life
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Figure 37. The relationship between the 
average number of hospice days among 
cancer patients (last month of life) and all 
chronically ill patients (last six months 
of life) among patients receiving most of 
their care at academic medical centers 
(deaths occurring 2003-07)
Like the other measures described in this section, 
the number of days chronically ill patients spent 
in hospice during the last six months of life was a 
strong predictor of day rates among cancer patients 
during the last month of life (R2 = 0.58).
Hospice days per chronically ill patient 
during the last six months of life
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Concluding thoughts
There is no greater challenge to patients, families and caregivers than when, against 
every hope and medical effort, illness worsens and death is imminent within weeks 
or months. Cancer patients, in particular, usually recognize the seriousness of their 
illness at the initial diagnosis and join with their doctors and nurses in the fight for 
a cure. Inability to achieve a cure is often felt to be a failure, and discussions of 
palliative and hospice care can sometimes be perceived as “giving up” by patients, 
families and clinicians. Discussions of end-of-life care are often polarized, fram-
ing patients’ choices as cure versus care, hospital versus hospice, and life versus 
death. This black and white view of the course of cancer and its care, whether it is 
embraced or simply followed as the local norm of care, is a disservice to patients 
whose wish is to live, but also to live well. Living well has a different meaning for 
each patient, and it is the responsibility of clinicians and health care systems to 
help patients articulate their goals for living and for their medical care, whether the 
expectation is to live for years or for a few months or weeks.
The patterns of end-of-life cancer care presented in this report are partly the 
expression of patient preferences, but much more of local approaches to care and 
patterns of practice. As well-intentioned as this care may be, in many hospitals and 
regions it reflects false assumptions about patient wishes, the difficulty of having 
serious conversations about end-of-life issues, and—at times—a failure to listen 
to the actual hopes and fears of patients and their families. Many patients find 
little opportunity to explore these preferences as the clinical team “fights” the battle 
against an illness that has no cure. The slow pace of adoption of early palliative 
care for patients with serious cancer is a tragic underservice of health care, leading 
to much unnecessary suffering. Progress has been made in palliative and hospice 
care in the past decades, but there remains more work to be done.
It may help both patients and clinicians to recognize that achieving both the longest 
and the most functional life is not a simple choice between curative and palliative 
or hospice care.22 Palliative care early in the course of cancer illness can reduce 
discomfort from the disease and from curative treatments, and also legitimize the 
discussion of quality of life. For patients with poor prognosis disease, palliative and 
hospice care can actually prolong life, even as they improve its quality.23-25 This 
Atlas report provides patients, clinicians, and health planners a guide to the regions 
and academic medical centers providing less intensive hospital care and higher 
levels of hospice services and to the places where further improvements in end-of-
life care are needed.
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Methods overview
This report, “Quality of End-of-Life Cancer Care in Medicare Beneficiaries,” used 
both methods developed specifically for patients with poor prognosis cancer and 
for the care received by other chronically ill Medicare beneficiaries at the end of life. 
A brief discussion of the methods can be found in this section, with more detailed 
descriptions to be found in peer-reviewed journal articles.26,27
Databases used in the analyses
Data sets used in the report included the Medicare Denominator file (information 
about beneficiary enrollment, age, gender and race), the 20% Carrier file (informa-
tion about clinician care with patient diagnoses and procedures), the MedPAR file 
(information about inpatient stays including ICU use, hospital days and diagnoses), 
the Outpatient file (information about facility charges such as outpatient chemo-
therapy administration) and the Hospice file.
Study populations
We identified a 20% sample of all Medicare beneficiaries who died between the 
ages of 66 and 99 years during the period 2003-07. We excluded beneficiaries 
without continuous Part A and Part B coverage in the last six months of life or 
who were enrolled in Medicare health maintenance organizations (i.e., Medicare 
Advantage). From these decedents, we identified those with poor prognosis can-
cer diagnoses28 on at least one hospital claim or at least two clinician visits in the 
last six months of life. We then categorized decedents into one of 26 cancer types 
based on their predominant cancer diagnosis using a modified Clinical Classifica-
tion Software (CCS) approach.29
Table 1. Number of cancer decedents by cancer type
CCS 
Category Cancer Type Hospital-specific
Hospital referral region-
specific
number of 
patients % of Cohort
number of 
patients % of Cohort
19 Cancer of bronchus/lung 66,978 30.98 74,581 31.63
41-44
Cancer of uncertain primary: other and unspecified 
primary, secondary malignancies, malignant 
neoplasm without specification of site, neoplasms of 
unspecified nature or uncertain behavior 
20,176 9.33 22,695 9.62
37-40 Hematologic cancer: Hodgkin’s, non-Hodgkin’s lymphoma, leukemia, multiple myeloma 19,879 9.19 21,012 8.91
14, 15 Cancer of colon/rectum/anus 18,392 8.51 18,994 8.05
17 Cancer of pancreas 13,361 6.18 15,076 6.39
39 Cancer of prostate 13,164 6.09 13,889 5.89
24 Cancer of breast 12,015 5.56 12,583 5.34
16 Cancer of liver and intrahepatic bile duct 6,356 2.94 7,342 3.11
other 45,897 21.23 49,649 21.05
total 216,218 100% 235,821 100%
Health Care Costs and Utilization Project - Agency for Healthcare Research and Quality. Clinical 
Classification Software (CCS) for ICD-9-CM 2009.
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Cohort members were assigned a CCS cancer category based on their predomi-
nant cancer diagnoses. Patients whose predominant ICD-9 codes resulted in 
assignment to the vaguely defined CCS cancer categories 41-44 were reassigned 
to more narrowly defined CCS categories if they had one or more cancer diagnoses 
belonging to a more specific CCS category. For patients without a specific cancer 
diagnosis, assignment to a more narrowly defined CCS category was achieved, 
when possible, by including a broader range of cancer diagnoses (ICD-9 codes 
140-208 or 239.0-239.9 excluding V codes) in cancer diagnosis events. Ties were 
resolved by assigning the patient to the CCS category corresponding to the diag-
nosis most proximal to death.
Decedents with hospitalization were assigned to the hospital providing the most 
cancer care hospitalizations in the last six months of life. These were identified as 
inpatient stays with a primary diagnosis of cancer (ICD-9 codes 140-209, 236-239 
excluding V codes) or secondary diagnosis of a poor prognosis cancer ICD-9 code. 
We restricted the hospitals in this report to National Cancer Institute (NCI) cancer 
centers and non-NCI-affiliated academic medical centers (AMC) using the NCI web 
site member list (confirmed by NCI staff) and the American Association of Medical 
Colleges Council of Teaching Hospitals and Health Systems 2007 hospital aca-
demic affiliation definitions. Hospitals not in NCI or AMC groups were categorized 
as community hospitals; while not discussed in this report, measures of the care 
they provided to poor prognosis cancer patients can be found on the Dartmouth 
Atlas web site (www.dartmouthatlas.org).
Appendix Table. Utilization of care during the last month of life among cancer patients dying between 2003 and 2007 and 
receiving most of their care at selected academic medical centers.
Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
university of alabama Hospital Birmingham, al 208 30.6 59.9 5.1 23.8 1.4 10.9 62.2 11.4 university of alabama Hospital
st. Joseph’s Hospital & Medical Center Phoenix, aZ 82 18.9 58.5 4.8 34.7 1.5 13.5 67.4 10.9 13.0 st. Joseph’s Hospital & Medical Center
university Medical Center tucson, aZ 85 29.7 61.7 4.9 37.3 2.0 13.7 50.6 7.0 university Medical Center
uaMs Medical Center little rock, ar 132 30.4 57.9 5.9 30.7 1.2 7.7 8.7 59.3 10.0 9.9 uaMs Medical Center
City of Hope national Medical Center duarte, Ca 99 35.3 65.4 6.1 19.0 1.3 50.2 6.1 City of Hope national Medical Center
loma linda university Medical Center loma linda, Ca 109 24.1 57.3 5.3 37.8 2.2 13.1 61.7 9.8 10.1 loma linda university Medical Center
Cedars-sinai Medical Center los angeles, Ca 348 51.9 72.3 7.9 40.1 2.4 18.3 11.5 33.7 4.4 8.3 Cedars-sinai Medical Center
uCla Medical Center los angeles, Ca 143 38.8 63.4 6.6 41.2 2.8 10.9 48.4 6.1 8.4 uCla Medical Center
university of California davis Medical Center sacramento, Ca 108 26.3 52.3 3.7 34.4 1.2 12.0 53.1 9.5 university of California davis Medical Center
uCsf Medical Center san francisco, Ca 153 36.2 61.3 6.1 26.4 1.2 9.1 45.3 7.5 uCsf Medical Center
stanford Hospital and Clinics stanford, Ca 163 31.9 60.6 5.0 32.2 1.3 52.9 9.0 7.2 stanford Hospital and Clinics
Bridgeport Hospital Bridgeport, Ct 119 42.8 68.2 6.5 36.1 1.9 12.7 55.3 6.0 12.0 Bridgeport Hospital
Hartford Hospital Hartford, Ct 312 44.0 67.9 6.3 18.0 0.8 9.1 4.1 44.6 5.8 9.4 Hartford Hospital
st. francis Hospital and Medical Center Hartford, Ct 260 31.8 59.8 5.4 11.4 0.3 10.0 44.4 6.7 8.5 st. francis Hospital and Medical Center
1. Blank cells indicate that there was not enough utilization among cancer patients during the last month of life to report the measure.    
2. The statistical precision of these rates varies according to population size. A table for all hospitals with a sufficient population of cancer decedents, including both rates and confidence limits, is 
available on the Downloads page of our web site: http://www.dartmouthatlas.org/downloads.aspx.
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All cancer decedents were also assigned to the hospital referral region of their resi-
dence. Hospital referral regions (N = 306) are geographic markets for tertiary care 
for Medicare beneficiaries that were defined using information about beneficiaries’ 
travel for cardiothoracic and neurosurgery. More information about how hospital 
referral regions were defined is available on our web site.
End-of-life care
For each patient, we identified hospitalizations, hospital days, intensive care unit 
(ICU) admissions and days, and the number of unique physicians providing care. 
We used discharge status of “expired” to identify patients dying in the hospital. 
We also measured the number of days of hospice use for each patient and late 
initiation of hospice service (within three or fewer days of death). We used specific 
billing codes (from the MedPAR, Carrier, and Outpatient files) to assess receipt 
of chemotherapy (administered by a clinician or facility) and three potentially life-
sustaining procedures: (1) feeding tube placement (2) endotracheal intubation and 
(3) cardiopulmonary resuscitation.
Statistical analyses
Although all of these patients died of serious cancer, groups of patients across hos-
pitals or regions may have differed by other characteristics such as the composition 
of age, gender or race. All rates are adjusted with the following patient level char-
acteristics: age (categorized as 66-69, 70-74, 75-79, 80-84, 85-99), race (black/
non-black), gender, cancer type, and non-cancer chronic conditions.
Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
university of alabama Hospital Birmingham, al 208 30.6 59.9 5.1 23.8 1.4 10.9 62.2 11.4 university of alabama Hospital
st. Joseph’s Hospital & Medical Center Phoenix, aZ 82 18.9 58.5 4.8 34.7 1.5 13.5 67.4 10.9 13.0 st. Joseph’s Hospital & Medical Center
university Medical Center tucson, aZ 85 29.7 61.7 4.9 37.3 2.0 13.7 50.6 7.0 university Medical Center
uaMs Medical Center little rock, ar 132 30.4 57.9 5.9 30.7 1.2 7.7 8.7 59.3 10.0 9.9 uaMs Medical Center
City of Hope national Medical Center duarte, Ca 99 35.3 65.4 6.1 19.0 1.3 50.2 6.1 City of Hope national Medical Center
loma linda university Medical Center loma linda, Ca 109 24.1 57.3 5.3 37.8 2.2 13.1 61.7 9.8 10.1 loma linda university Medical Center
Cedars-sinai Medical Center los angeles, Ca 348 51.9 72.3 7.9 40.1 2.4 18.3 11.5 33.7 4.4 8.3 Cedars-sinai Medical Center
uCla Medical Center los angeles, Ca 143 38.8 63.4 6.6 41.2 2.8 10.9 48.4 6.1 8.4 uCla Medical Center
university of California davis Medical Center sacramento, Ca 108 26.3 52.3 3.7 34.4 1.2 12.0 53.1 9.5 university of California davis Medical Center
uCsf Medical Center san francisco, Ca 153 36.2 61.3 6.1 26.4 1.2 9.1 45.3 7.5 uCsf Medical Center
stanford Hospital and Clinics stanford, Ca 163 31.9 60.6 5.0 32.2 1.3 52.9 9.0 7.2 stanford Hospital and Clinics
Bridgeport Hospital Bridgeport, Ct 119 42.8 68.2 6.5 36.1 1.9 12.7 55.3 6.0 12.0 Bridgeport Hospital
Hartford Hospital Hartford, Ct 312 44.0 67.9 6.3 18.0 0.8 9.1 4.1 44.6 5.8 9.4 Hartford Hospital
st. francis Hospital and Medical Center Hartford, Ct 260 31.8 59.8 5.4 11.4 0.3 10.0 44.4 6.7 8.5 st. francis Hospital and Medical Center
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
Hospital of st. raphael new Haven, Ct 250 30.9 63.2 5.7 22.5 1.0 9.1 8.6 54.4 8.0 7.2 Hospital of st. raphael
yale-new Haven Hospital new Haven, Ct 220 24.6 65.3 5.7 17.3 0.8 13.2 65.6 10.0 7.5 yale-new Haven Hospital
Medstar-Georgetown Medical Center Washington, dC 103 38.7 61.1 6.4 22.2 1.3 17.2 46.7 7.0 Medstar-Georgetown Medical Center
Washington Hospital Center Washington, dC 193 36.6 63.6 6.7 27.4 1.3 11.0 45.5 6.6 Washington Hospital Center
shands at the university of florida Gainesville, fl 151 30.9 58.0 5.6 31.8 1.9 12.6 8.6 57.8 9.9 shands at the university of florida
shands Jacksonville Medical Center Jacksonville, fl 95 29.4 67.1 4.8 26.2 1.4 15.5 68.4 11.0 shands Jacksonville Medical Center
Jackson Memorial Hospital Miami, fl 118 36.0 59.7 7.0 32.1 2.5 21.7 53.1 7.2 Jackson Memorial Hospital
H. lee Moffitt Cancer Center tampa, fl 177 28.1 49.9 4.8 25.5 1.2 14.1 7.7 63.0 10.2 7.6 H. lee Moffitt Cancer Center
tampa General Hospital tampa, fl 109 26.7 55.0 6.8 37.1 2.1 12.7 65.6 10.6 tampa General Hospital
Emory university Hospital atlanta, Ga 192 35.0 59.4 6.0 32.5 2.2 13.2 6.2 55.1 8.4 8.9 Emory university Hospital
Macneal Hospital Berwyn, il 102 25.6 65.1 4.5 29.5 1.3 56.3 8.5 11.6 Macneal Hospital
northwestern Memorial Hospital Chicago, il 273 37.9 62.0 6.1 24.2 1.2 12.9 5.2 52.3 9.6 8.6 northwestern Memorial Hospital
rush university Medical Center Chicago, il 194 33.2 68.8 6.1 34.7 1.5 20.8 50.5 6.9 11.0 rush university Medical Center
university of Chicago Hospital Chicago, il 241 28.6 60.5 5.7 24.4 1.5 13.1 5.0 60.6 9.3 8.3 university of Chicago Hospital
Evanston northwestern Healthcare Evanston, il 324 18.7 58.8 5.2 42.8 2.8 5.8 3.6 72.1 10.7 13.3 Evanston northwestern Healthcare
loyola university Medical Center Maywood, il 186 25.0 62.4 5.2 30.9 2.0 8.6 62.8 10.0 10.8 loyola university Medical Center
advocate Christ Medical Center oak lawn, il 300 25.8 67.2 5.7 29.2 1.2 15.0 7.3 54.8 6.7 13.3 advocate Christ Medical Center
advocate lutheran General Hospital Park ridge, il 266 26.6 69.4 5.2 31.0 1.1 13.5 10.4 60.7 7.7 12.1 advocate lutheran General Hospital
Memorial Medical Center springfield, il 215 32.9 62.6 5.8 21.2 1.1 10.8 45.6 7.6 6.4 Memorial Medical Center
Clarian Health Partners indianapolis, in 337 28.4 55.1 4.6 25.8 1.1 9.7 5.8 54.9 9.0 7.7 Clarian Health Partners
university of iowa Hospitals & Clinics iowa City, ia 173 24.0 48.1 4.1 17.4 0.6 10.5 62.9 12.5 university of iowa Hospitals & Clinics
university of Kansas Hospital Kansas City, Ks 104 32.5 58.1 6.4 28.8 1.5 48.0 8.3 university of Kansas Hospital
university of Kentucky Hospital lexington, Ky 121 25.9 60.8 5.7 29.1 1.4 56.6 10.2 university of Kentucky Hospital
ochsner Clinic foundation new orleans, la 84 24.1 67.1 5.6 23.0 1.4 12.5 67.0 9.8 ochsner Clinic foundation
Maine Medical Center Portland, ME 241 35.5 62.9 5.8 16.1 0.5 4.7 5.6 32.7 5.9 Maine Medical Center
Johns Hopkins Bayview Medical Center Baltimore, Md 108 23.0 61.1 4.3 25.5 0.9 10.6 62.9 9.9 Johns Hopkins Bayview Medical Center
Johns Hopkins Hospital Baltimore, Md 239 23.7 57.0 5.5 18.5 0.8 9.2 3.8 59.3 9.9 6.3 Johns Hopkins Hospital
university of Maryland Medical Center Baltimore, Md 122 37.5 65.8 6.4 40.7 2.4 16.6 49.8 7.6 10.2 university of Maryland Medical Center
Beth israel deaconess Medical Center Boston, Ma 203 32.3 62.8 6.2 28.5 1.6 12.7 49.1 7.1 10.3 Beth israel deaconess Medical Center
Boston Medical Center Boston, Ma 99 38.3 67.6 6.3 21.7 1.1 46.2 8.0 Boston Medical Center
Brigham and Women’s Hospital Boston, Ma 345 33.2 62.6 5.9 25.2 1.0 10.5 4.8 48.7 7.4 6.5 Brigham and Women’s Hospital
Massachusetts General Hospital Boston, Ma 394 30.9 56.9 5.6 15.0 0.6 6.7 51.5 8.0 8.4 Massachusetts General Hospital
Caritas st. Elizabeth’s Medical Center Brighton, Ma 86 32.4 71.2 7.1 16.4 0.9 44.5 6.0 Caritas st. Elizabeth’s Medical Center
lahey Clinic Hospital Burlington, Ma 176 36.3 71.8 6.5 33.9 2.2 14.9 45.0 5.7 10.0 lahey Clinic Hospital
Berkshire Medical Center Pittsfield, Ma 131 22.8 61.6 5.1 12.9 0.5 11.0 9.1 63.2 8.9 13.6 Berkshire Medical Center
Baystate Medical Center springfield, Ma 184 34.3 63.5 5.8 12.9 0.5 8.8 47.4 8.2 6.5 Baystate Medical Center
uMass Memorial Medical Center Worcester, Ma 202 33.1 62.6 5.4 19.5 0.8 8.9 46.7 7.7 5.8 uMass Memorial Medical Center
st. Joseph Mercy Hospital ann arbor, Mi 247 22.5 60.8 4.2 36.6 1.6 6.9 6.3 68.2 11.5 10.1 st. Joseph Mercy Hospital
university of Michigan Hospitals ann arbor, Mi 215 23.1 56.3 4.8 20.7 0.8 11.8 65.1 10.8 9.1 university of Michigan Hospitals
Harper university Hospital detroit, Mi 150 29.0 70.8 6.5 23.1 1.3 12.6 64.6 7.6 13.6 Harper university Hospital
Henry ford Hospital detroit, Mi 269 29.9 61.8 5.5 24.1 1.2 14.9 60.3 9.1 12.0 Henry ford Hospital
Appendix Table (continued). Utilization of care during the last month of life among cancer patients dying between 2003 and 
2007 and receiving most of their care at selected academic medical centers.
1. Blank cells indicate that there was not enough utilization among cancer patients during the last month of life to report the measure.    
2. The statistical precision of these rates varies according to population size. A table for all hospitals with a sufficient population of cancer decedents, including both rates and confidence limits, is 
available on the Downloads page of our web site: http://www.dartmouthatlas.org/downloads.aspx.
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
Hospital of st. raphael new Haven, Ct 250 30.9 63.2 5.7 22.5 1.0 9.1 8.6 54.4 8.0 7.2 Hospital of st. raphael
yale-new Haven Hospital new Haven, Ct 220 24.6 65.3 5.7 17.3 0.8 13.2 65.6 10.0 7.5 yale-new Haven Hospital
Medstar-Georgetown Medical Center Washington, dC 103 38.7 61.1 6.4 22.2 1.3 17.2 46.7 7.0 Medstar-Georgetown Medical Center
Washington Hospital Center Washington, dC 193 36.6 63.6 6.7 27.4 1.3 11.0 45.5 6.6 Washington Hospital Center
shands at the university of florida Gainesville, fl 151 30.9 58.0 5.6 31.8 1.9 12.6 8.6 57.8 9.9 shands at the university of florida
shands Jacksonville Medical Center Jacksonville, fl 95 29.4 67.1 4.8 26.2 1.4 15.5 68.4 11.0 shands Jacksonville Medical Center
Jackson Memorial Hospital Miami, fl 118 36.0 59.7 7.0 32.1 2.5 21.7 53.1 7.2 Jackson Memorial Hospital
H. lee Moffitt Cancer Center tampa, fl 177 28.1 49.9 4.8 25.5 1.2 14.1 7.7 63.0 10.2 7.6 H. lee Moffitt Cancer Center
tampa General Hospital tampa, fl 109 26.7 55.0 6.8 37.1 2.1 12.7 65.6 10.6 tampa General Hospital
Emory university Hospital atlanta, Ga 192 35.0 59.4 6.0 32.5 2.2 13.2 6.2 55.1 8.4 8.9 Emory university Hospital
Macneal Hospital Berwyn, il 102 25.6 65.1 4.5 29.5 1.3 56.3 8.5 11.6 Macneal Hospital
northwestern Memorial Hospital Chicago, il 273 37.9 62.0 6.1 24.2 1.2 12.9 5.2 52.3 9.6 8.6 northwestern Memorial Hospital
rush university Medical Center Chicago, il 194 33.2 68.8 6.1 34.7 1.5 20.8 50.5 6.9 11.0 rush university Medical Center
university of Chicago Hospital Chicago, il 241 28.6 60.5 5.7 24.4 1.5 13.1 5.0 60.6 9.3 8.3 university of Chicago Hospital
Evanston northwestern Healthcare Evanston, il 324 18.7 58.8 5.2 42.8 2.8 5.8 3.6 72.1 10.7 13.3 Evanston northwestern Healthcare
loyola university Medical Center Maywood, il 186 25.0 62.4 5.2 30.9 2.0 8.6 62.8 10.0 10.8 loyola university Medical Center
advocate Christ Medical Center oak lawn, il 300 25.8 67.2 5.7 29.2 1.2 15.0 7.3 54.8 6.7 13.3 advocate Christ Medical Center
advocate lutheran General Hospital Park ridge, il 266 26.6 69.4 5.2 31.0 1.1 13.5 10.4 60.7 7.7 12.1 advocate lutheran General Hospital
Memorial Medical Center springfield, il 215 32.9 62.6 5.8 21.2 1.1 10.8 45.6 7.6 6.4 Memorial Medical Center
Clarian Health Partners indianapolis, in 337 28.4 55.1 4.6 25.8 1.1 9.7 5.8 54.9 9.0 7.7 Clarian Health Partners
university of iowa Hospitals & Clinics iowa City, ia 173 24.0 48.1 4.1 17.4 0.6 10.5 62.9 12.5 university of iowa Hospitals & Clinics
university of Kansas Hospital Kansas City, Ks 104 32.5 58.1 6.4 28.8 1.5 48.0 8.3 university of Kansas Hospital
university of Kentucky Hospital lexington, Ky 121 25.9 60.8 5.7 29.1 1.4 56.6 10.2 university of Kentucky Hospital
ochsner Clinic foundation new orleans, la 84 24.1 67.1 5.6 23.0 1.4 12.5 67.0 9.8 ochsner Clinic foundation
Maine Medical Center Portland, ME 241 35.5 62.9 5.8 16.1 0.5 4.7 5.6 32.7 5.9 Maine Medical Center
Johns Hopkins Bayview Medical Center Baltimore, Md 108 23.0 61.1 4.3 25.5 0.9 10.6 62.9 9.9 Johns Hopkins Bayview Medical Center
Johns Hopkins Hospital Baltimore, Md 239 23.7 57.0 5.5 18.5 0.8 9.2 3.8 59.3 9.9 6.3 Johns Hopkins Hospital
university of Maryland Medical Center Baltimore, Md 122 37.5 65.8 6.4 40.7 2.4 16.6 49.8 7.6 10.2 university of Maryland Medical Center
Beth israel deaconess Medical Center Boston, Ma 203 32.3 62.8 6.2 28.5 1.6 12.7 49.1 7.1 10.3 Beth israel deaconess Medical Center
Boston Medical Center Boston, Ma 99 38.3 67.6 6.3 21.7 1.1 46.2 8.0 Boston Medical Center
Brigham and Women’s Hospital Boston, Ma 345 33.2 62.6 5.9 25.2 1.0 10.5 4.8 48.7 7.4 6.5 Brigham and Women’s Hospital
Massachusetts General Hospital Boston, Ma 394 30.9 56.9 5.6 15.0 0.6 6.7 51.5 8.0 8.4 Massachusetts General Hospital
Caritas st. Elizabeth’s Medical Center Brighton, Ma 86 32.4 71.2 7.1 16.4 0.9 44.5 6.0 Caritas st. Elizabeth’s Medical Center
lahey Clinic Hospital Burlington, Ma 176 36.3 71.8 6.5 33.9 2.2 14.9 45.0 5.7 10.0 lahey Clinic Hospital
Berkshire Medical Center Pittsfield, Ma 131 22.8 61.6 5.1 12.9 0.5 11.0 9.1 63.2 8.9 13.6 Berkshire Medical Center
Baystate Medical Center springfield, Ma 184 34.3 63.5 5.8 12.9 0.5 8.8 47.4 8.2 6.5 Baystate Medical Center
uMass Memorial Medical Center Worcester, Ma 202 33.1 62.6 5.4 19.5 0.8 8.9 46.7 7.7 5.8 uMass Memorial Medical Center
st. Joseph Mercy Hospital ann arbor, Mi 247 22.5 60.8 4.2 36.6 1.6 6.9 6.3 68.2 11.5 10.1 st. Joseph Mercy Hospital
university of Michigan Hospitals ann arbor, Mi 215 23.1 56.3 4.8 20.7 0.8 11.8 65.1 10.8 9.1 university of Michigan Hospitals
Harper university Hospital detroit, Mi 150 29.0 70.8 6.5 23.1 1.3 12.6 64.6 7.6 13.6 Harper university Hospital
Henry ford Hospital detroit, Mi 269 29.9 61.8 5.5 24.1 1.2 14.9 60.3 9.1 12.0 Henry ford Hospital
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
sinai-Grace Hospital detroit, Mi 103 35.2 75.3 7.2 24.2 1.3 14.3 47.9 6.7 sinai-Grace Hospital
st. John Hospital & Medical Center detroit, Mi 236 32.7 78.1 7.2 46.1 2.5 14.9 9.1 57.0 5.9 19.3 st. John Hospital & Medical Center
Mclaren regional Medical Center flint, Mi 162 24.0 72.1 5.7 25.9 1.0 9.7 9.7 71.1 9.1 14.3 Mclaren regional Medical Center
ingham regional Medical Center lansing, Mi 142 26.7 70.5 6.5 18.2 0.7 65.2 8.7 11.1 ingham regional Medical Center
Beaumont Hospital royal oak, Mi 491 29.7 70.7 7.4 21.7 1.1 15.6 8.3 62.2 7.5 13.6 Beaumont Hospital
university of Minnesota Medical Center Minneapolis, Mn 106 24.9 59.6 5.5 25.5 1.1 59.0 9.5 10.2 university of Minnesota Medical Center
st. Mary’s Hospital rochester, Mn 280 23.2 55.1 4.6 30.1 1.2 6.6 55.1 9.5 10.0 st. Mary’s Hospital
university of Missouri Hospital & Clinic Columbia, Mo 96 39.7 70.2 6.6 42.0 2.0 15.7 43.9 7.8 university of Missouri Hospital & Clinic
st. luke’s Hospital Kansas City, Mo 112 32.9 56.8 5.1 36.8 2.3 12.6 54.2 9.2 st. luke’s Hospital
ssM st. Mary’s Health Center richmond Heights, Mo 114 25.2 67.2 5.3 29.1 1.4 63.1 7.8 17.3 ssM st. Mary’s Health Center
Barnes-Jewish Hospital st. louis, Mo 405 29.0 61.6 5.6 19.2 0.8 14.0 4.6 56.9 8.2 10.8 Barnes-Jewish Hospital
nebraska Medical Center omaha, nE 155 39.6 66.9 6.7 41.6 3.0 9.5 43.9 6.1 9.6 nebraska Medical Center
dartmouth-Hitchcock Medical Center lebanon, nH 201 26.0 52.2 4.4 16.2 0.5 9.4 5.4 42.1 7.5 dartmouth-Hitchcock Medical Center
Cooper Health system Camden, nJ 87 40.7 74.1 6.7 49.2 3.5 17.9 50.5 7.8 13.3 Cooper Health system
Monmouth Medical Center long Branch, nJ 109 20.2 69.7 5.4 35.1 1.7 73.0 9.0 15.6 Monmouth Medical Center
robert Wood Johnson university Hospital new Brunswick, nJ 217 42.5 61.4 7.2 31.0 1.9 16.6 8.5 47.5 6.8 8.7 robert Wood Johnson university Hospital
newark Beth israel Medical Center newark, nJ 81 36.7 71.8 8.7 41.8 2.7 16.7 46.0 5.0 newark Beth israel Medical Center
albany Medical Center albany, ny 82 32.1 54.3 4.5 15.2 0.5 51.1 8.5 albany Medical Center
Montefiore Medical Center Bronx, ny 223 32.1 64.1 6.6 12.1 0.6 12.4 6.1 18.6 2.7 Montefiore Medical Center
Maimonides Medical Center Brooklyn, ny 176 54.3 69.8 7.8 22.9 7.5 31.1 4.3 Maimonides Medical Center
new york Methodist Hospital Brooklyn, ny 151 54.9 73.6 8.6 17.1 0.9 26.7 21.0 3.6 new york Methodist Hospital
Kaleida Health-Buffalo General Hospital Buffalo, ny 239 29.7 61.1 5.8 19.4 0.8 9.3 5.2 50.7 7.6 11.9 Kaleida Health-Buffalo General Hospital
roswell Park Cancer institute Buffalo, ny 92 40.0 62.7 6.3 18.3 0.7 46.8 6.4 roswell Park Cancer institute
Mary imogene Bassett Hospital Cooperstown, ny 117 33.8 69.0 6.3 36.4 2.2 11.0 51.3 7.0 11.6 Mary imogene Bassett Hospital
north shore university Hospital Manhasset, ny 429 46.9 67.8 7.6 19.1 0.9 15.1 8.5 41.2 6.3 5.1 north shore university Hospital
Winthrop-university Hospital Mineola, ny 217 40.8 69.2 8.5 23.1 1.5 10.3 11.1 44.4 5.6 11.6 Winthrop-university Hospital
long island Jewish Medical Center new Hyde Park, ny 206 47.0 67.9 7.0 14.2 0.6 12.8 5.7 33.7 5.5 long island Jewish Medical Center
Beth israel Medical Center new york, ny 207 41.3 71.1 7.5 21.8 1.1 18.7 43.6 6.4 7.5 Beth israel Medical Center
lenox Hill Hospital new york, ny 137 49.8 61.1 7.1 12.5 0.5 20.8 12.2 28.7 4.0 lenox Hill Hospital
Memorial sloan-Kettering Cancer Center new york, ny 665 34.3 56.3 6.3 8.9 0.4 8.2 4.4 41.7 7.0 3.4 Memorial sloan-Kettering Cancer Center
Mount sinai Hospital new york, ny 304 45.0 65.6 7.2 16.9 1.0 16.3 6.0 28.1 5.2 5.1 Mount sinai Hospital
new york university Medical Center new york, ny 220 42.9 63.2 7.4 31.3 1.8 14.7 5.9 32.4 5.3 new york university Medical Center
new york-Presbyterian Hospital new york, ny 490 46.2 63.9 7.6 19.2 1.2 17.5 7.1 24.9 3.8 4.1 new york-Presbyterian Hospital
st. luke’s-roosevelt Hospital Center new york, ny 129 39.5 64.7 6.7 14.9 0.5 12.6 41.8 7.8 st. luke’s-roosevelt Hospital Center
st. Vincent’s Hospital new york, ny 131 30.4 57.9 7.3 16.8 1.1 12.2 35.8 6.2 st. Vincent’s Hospital
strong Memorial Hospital rochester, ny 138 22.4 55.7 4.8 16.3 0.7 8.7 61.9 9.4 10.6 strong Memorial Hospital
staten island university Hospital staten island, ny 156 44.6 74.0 6.9 24.6 0.9 16.1 41.5 6.0 7.7 staten island university Hospital
stony Brook university Hospital stony Brook, ny 125 44.2 68.0 6.8 15.6 0.7 13.7 49.1 8.0 stony Brook university Hospital
upstate Medical university syracuse, ny 140 39.1 58.8 6.4 14.8 1.0 9.2 41.2 8.4 upstate Medical university
Westchester Medical Center Valhalla, ny 81 57.3 57.8 8.7 16.2 1.3 18.1 18.6 2.8 Westchester Medical Center
university of north Carolina Hospitals Chapel Hill, nC 180 31.5 61.0 5.5 29.2 1.4 14.3 59.6 9.9 9.2 university of north Carolina Hospitals
Appendix Table, continued. Utilization of care during the last month of life among cancer patients dying between 2003 and 
2007 and receiving most of their care at selected academic medical centers.
1. Blank cells indicate that there was not enough utilization among cancer patients during the last month of life to report the measure.    
2. The statistical precision of these rates varies according to population size. A table for all hospitals with a sufficient population of cancer decedents, including both rates and confidence limits, is 
available on the Downloads page of our web site: http://www.dartmouthatlas.org/downloads.aspx.
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
sinai-Grace Hospital detroit, Mi 103 35.2 75.3 7.2 24.2 1.3 14.3 47.9 6.7 sinai-Grace Hospital
st. John Hospital & Medical Center detroit, Mi 236 32.7 78.1 7.2 46.1 2.5 14.9 9.1 57.0 5.9 19.3 st. John Hospital & Medical Center
Mclaren regional Medical Center flint, Mi 162 24.0 72.1 5.7 25.9 1.0 9.7 9.7 71.1 9.1 14.3 Mclaren regional Medical Center
ingham regional Medical Center lansing, Mi 142 26.7 70.5 6.5 18.2 0.7 65.2 8.7 11.1 ingham regional Medical Center
Beaumont Hospital royal oak, Mi 491 29.7 70.7 7.4 21.7 1.1 15.6 8.3 62.2 7.5 13.6 Beaumont Hospital
university of Minnesota Medical Center Minneapolis, Mn 106 24.9 59.6 5.5 25.5 1.1 59.0 9.5 10.2 university of Minnesota Medical Center
st. Mary’s Hospital rochester, Mn 280 23.2 55.1 4.6 30.1 1.2 6.6 55.1 9.5 10.0 st. Mary’s Hospital
university of Missouri Hospital & Clinic Columbia, Mo 96 39.7 70.2 6.6 42.0 2.0 15.7 43.9 7.8 university of Missouri Hospital & Clinic
st. luke’s Hospital Kansas City, Mo 112 32.9 56.8 5.1 36.8 2.3 12.6 54.2 9.2 st. luke’s Hospital
ssM st. Mary’s Health Center richmond Heights, Mo 114 25.2 67.2 5.3 29.1 1.4 63.1 7.8 17.3 ssM st. Mary’s Health Center
Barnes-Jewish Hospital st. louis, Mo 405 29.0 61.6 5.6 19.2 0.8 14.0 4.6 56.9 8.2 10.8 Barnes-Jewish Hospital
nebraska Medical Center omaha, nE 155 39.6 66.9 6.7 41.6 3.0 9.5 43.9 6.1 9.6 nebraska Medical Center
dartmouth-Hitchcock Medical Center lebanon, nH 201 26.0 52.2 4.4 16.2 0.5 9.4 5.4 42.1 7.5 dartmouth-Hitchcock Medical Center
Cooper Health system Camden, nJ 87 40.7 74.1 6.7 49.2 3.5 17.9 50.5 7.8 13.3 Cooper Health system
Monmouth Medical Center long Branch, nJ 109 20.2 69.7 5.4 35.1 1.7 73.0 9.0 15.6 Monmouth Medical Center
robert Wood Johnson university Hospital new Brunswick, nJ 217 42.5 61.4 7.2 31.0 1.9 16.6 8.5 47.5 6.8 8.7 robert Wood Johnson university Hospital
newark Beth israel Medical Center newark, nJ 81 36.7 71.8 8.7 41.8 2.7 16.7 46.0 5.0 newark Beth israel Medical Center
albany Medical Center albany, ny 82 32.1 54.3 4.5 15.2 0.5 51.1 8.5 albany Medical Center
Montefiore Medical Center Bronx, ny 223 32.1 64.1 6.6 12.1 0.6 12.4 6.1 18.6 2.7 Montefiore Medical Center
Maimonides Medical Center Brooklyn, ny 176 54.3 69.8 7.8 22.9 7.5 31.1 4.3 Maimonides Medical Center
new york Methodist Hospital Brooklyn, ny 151 54.9 73.6 8.6 17.1 0.9 26.7 21.0 3.6 new york Methodist Hospital
Kaleida Health-Buffalo General Hospital Buffalo, ny 239 29.7 61.1 5.8 19.4 0.8 9.3 5.2 50.7 7.6 11.9 Kaleida Health-Buffalo General Hospital
roswell Park Cancer institute Buffalo, ny 92 40.0 62.7 6.3 18.3 0.7 46.8 6.4 roswell Park Cancer institute
Mary imogene Bassett Hospital Cooperstown, ny 117 33.8 69.0 6.3 36.4 2.2 11.0 51.3 7.0 11.6 Mary imogene Bassett Hospital
north shore university Hospital Manhasset, ny 429 46.9 67.8 7.6 19.1 0.9 15.1 8.5 41.2 6.3 5.1 north shore university Hospital
Winthrop-university Hospital Mineola, ny 217 40.8 69.2 8.5 23.1 1.5 10.3 11.1 44.4 5.6 11.6 Winthrop-university Hospital
long island Jewish Medical Center new Hyde Park, ny 206 47.0 67.9 7.0 14.2 0.6 12.8 5.7 33.7 5.5 long island Jewish Medical Center
Beth israel Medical Center new york, ny 207 41.3 71.1 7.5 21.8 1.1 18.7 43.6 6.4 7.5 Beth israel Medical Center
lenox Hill Hospital new york, ny 137 49.8 61.1 7.1 12.5 0.5 20.8 12.2 28.7 4.0 lenox Hill Hospital
Memorial sloan-Kettering Cancer Center new york, ny 665 34.3 56.3 6.3 8.9 0.4 8.2 4.4 41.7 7.0 3.4 Memorial sloan-Kettering Cancer Center
Mount sinai Hospital new york, ny 304 45.0 65.6 7.2 16.9 1.0 16.3 6.0 28.1 5.2 5.1 Mount sinai Hospital
new york university Medical Center new york, ny 220 42.9 63.2 7.4 31.3 1.8 14.7 5.9 32.4 5.3 new york university Medical Center
new york-Presbyterian Hospital new york, ny 490 46.2 63.9 7.6 19.2 1.2 17.5 7.1 24.9 3.8 4.1 new york-Presbyterian Hospital
st. luke’s-roosevelt Hospital Center new york, ny 129 39.5 64.7 6.7 14.9 0.5 12.6 41.8 7.8 st. luke’s-roosevelt Hospital Center
st. Vincent’s Hospital new york, ny 131 30.4 57.9 7.3 16.8 1.1 12.2 35.8 6.2 st. Vincent’s Hospital
strong Memorial Hospital rochester, ny 138 22.4 55.7 4.8 16.3 0.7 8.7 61.9 9.4 10.6 strong Memorial Hospital
staten island university Hospital staten island, ny 156 44.6 74.0 6.9 24.6 0.9 16.1 41.5 6.0 7.7 staten island university Hospital
stony Brook university Hospital stony Brook, ny 125 44.2 68.0 6.8 15.6 0.7 13.7 49.1 8.0 stony Brook university Hospital
upstate Medical university syracuse, ny 140 39.1 58.8 6.4 14.8 1.0 9.2 41.2 8.4 upstate Medical university
Westchester Medical Center Valhalla, ny 81 57.3 57.8 8.7 16.2 1.3 18.1 18.6 2.8 Westchester Medical Center
university of north Carolina Hospitals Chapel Hill, nC 180 31.5 61.0 5.5 29.2 1.4 14.3 59.6 9.9 9.2 university of north Carolina Hospitals
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
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the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
Carolinas Medical Center Charlotte, nC 219 36.4 63.2 6.4 33.9 2.5 13.6 4.7 54.1 10.2 Carolinas Medical Center
duke university Hospital durham, nC 348 29.8 53.4 5.1 20.7 0.9 9.1 4.7 57.4 11.4 4.9 duke university Hospital
Pitt County Memorial Hospital Greenville, nC 230 38.9 58.5 4.9 26.3 1.5 9.1 5.5 45.8 9.1 Pitt County Memorial Hospital
north Carolina Baptist Hospital Winston-salem, nC 232 33.5 63.1 6.2 32.1 1.5 14.6 5.4 59.3 10.3 6.4 north Carolina Baptist Hospital
akron General Medical Center akron, oH 189 21.4 67.5 5.3 20.8 0.4 6.7 69.2 8.5 13.0 akron General Medical Center
summa Health system akron, oH 175 26.8 67.7 5.9 29.0 1.4 9.7 63.8 9.2 10.4 summa Health system
university Hospital Cincinnati, oH 102 26.6 69.2 6.0 40.2 2.1 19.3 63.2 8.6 12.4 university Hospital
Cleveland Clinic foundation Cleveland, oH 347 32.4 55.9 6.0 19.0 0.7 11.1 2.9 56.9 10.3 5.0 Cleveland Clinic foundation
MetroHealth Medical Center Cleveland, oH 80 34.4 66.3 4.8 28.7 1.5 63.4 11.4 MetroHealth Medical Center
university Hospitals of Cleveland Cleveland, oH 241 24.2 65.3 4.7 23.0 0.7 10.6 70.6 11.1 14.3 university Hospitals of Cleveland
ohio state university Medical Center Columbus, oH 141 27.0 59.5 5.7 23.4 1.4 13.7 53.0 8.1 ohio state university Medical Center
Western reserve Care system youngstown, oH 128 34.9 62.5 4.7 12.5 0.6 9.3 42.3 7.4 Western reserve Care system
oklahoma university Medical Center oklahoma City, oK 90 30.9 50.8 4.3 22.6 0.9 13.9 52.1 9.8 oklahoma university Medical Center
st. luke’s Hospital Bethlehem, Pa 218 20.3 66.6 6.2 31.8 1.8 9.2 6.3 65.6 9.4 12.2 st. luke’s Hospital
Geisinger Medical Center danville, Pa 128 30.5 65.9 4.9 17.1 0.5 51.6 7.5 10.7 Geisinger Medical Center
Penn state Hershey Medical Center Hershey, Pa 188 36.1 60.2 6.0 37.6 2.3 14.1 7.1 44.1 7.0 6.7 Penn state Hershey Medical Center
fox Chase Cancer Center Philadelphia, Pa 111 28.9 60.7 6.8 30.3 1.7 11.3 63.8 9.7 11.5 fox Chase Cancer Center
Hospital of the university of Pennsylvania Philadelphia, Pa 178 38.3 57.5 5.9 27.7 1.3 14.7 53.0 7.8 8.7 Hospital of the university of Pennsylvania
thomas Jefferson university Hospital Philadelphia, Pa 189 34.7 60.0 6.7 42.4 3.3 12.1 52.4 6.7 10.9 thomas Jefferson university Hospital
allegheny General Hospital Pittsburgh, Pa 124 38.0 71.5 8.4 46.0 4.1 24.8 43.5 6.7 allegheny General Hospital
Mercy Hospital of Pittsburgh Pittsburgh, Pa 81 31.6 63.8 6.7 16.8 1.1 55.2 7.4 14.0 Mercy Hospital of Pittsburgh
uPMC Presbyterian shadyside Pittsburgh, Pa 370 27.7 65.3 6.1 29.3 1.2 11.7 3.9 53.5 7.1 13.1 uPMC Presbyterian shadyside
lankenau Hospital Wynnewood, Pa 97 31.1 70.1 6.1 43.7 3.2 14.5 56.3 8.2 lankenau Hospital
york Hospital york, Pa 216 29.6 65.5 5.6 20.2 0.9 8.2 5.9 47.3 7.0 10.5 york Hospital
rhode island Hospital Providence, ri 165 29.8 62.2 5.9 25.4 1.4 9.8 8.1 58.7 8.6 12.0 rhode island Hospital
MusC Medical Center Charleston, sC 124 24.5 60.6 5.0 28.7 1.8 7.4 65.8 11.8 9.3 MusC Medical Center
Erlanger Medical Center Chattanooga, tn 131 28.8 61.6 6.4 22.3 1.3 7.7 60.2 9.9 Erlanger Medical Center
university of tennessee Medical Center Knoxville, tn 133 36.8 65.6 6.4 26.8 1.0 9.0 8.3 44.7 6.4 university of tennessee Medical Center
Vanderbilt university Medical Center nashville, tn 156 25.2 54.4 4.7 33.5 2.1 11.0 58.0 10.7 7.0 Vanderbilt university Medical Center
university of texas Medical Branch Hospitals Galveston, tX 110 25.0 54.7 4.7 17.4 0.7 63.4 11.2 university of texas Medical Branch Hospitals
university of texas M.d. anderson Cancer Ctr Houston, tX 613 28.8 57.7 5.8 25.8 1.8 6.6 6.7 61.2 10.0 7.2 university of texas M.d. anderson Cancer Ctr
university Medical Center lubbock, tX 80 30.6 62.2 5.9 16.3 1.1 66.7 12.8 university Medical Center
scott and White Memorial Hospital temple, tX 136 21.9 64.4 4.4 15.4 0.5 9.0 61.2 8.5 12.2 scott and White Memorial Hospital
university of utah Hospital salt lake City, ut 125 24.1 58.0 4.2 33.5 1.5 62.1 9.4 10.8 university of utah Hospital
fletcher allen Health Care Burlington, Vt 166 29.8 61.9 5.1 13.8 0.3 10.0 6.6 46.6 6.7 9.8 fletcher allen Health Care
university of Virginia Medical Center Charlottesville, Va 227 30.7 58.3 5.1 25.7 1.2 12.2 4.1 51.3 10.2 university of Virginia Medical Center
VCu Health system richmond, Va 118 31.8 65.6 5.8 25.4 1.6 49.1 8.6 VCu Health system
university of Washington Medical Center seattle, Wa 105 21.3 44.6 4.2 12.2 1.2 57.9 10.2 university of Washington Medical Center
West Virginia university Hospitals Morgantown, WV 102 26.6 59.2 5.7 32.6 2.2 10.7 51.3 9.5 West Virginia university Hospitals
university of Wisconsin Hospital & Clinics Madison, Wi 178 22.5 55.7 4.6 19.6 0.6 6.5 61.1 10.9 6.0 university of Wisconsin Hospital & Clinics
froedtert Memorial lutheran Hospital Milwaukee, Wi 164 19.6 63.2 4.7 18.7 0.5 6.7 66.2 10.8 7.8 froedtert Memorial lutheran Hospital
Appendix Table, continued. Utilization of care during the last month of life among cancer patients dying between 2003 and 
2007 and receiving most of their care at selected academic medical centers.
1. Blank cells indicate that there was not enough utilization among cancer patients during the last month of life to report the measure.    
2. The statistical precision of these rates varies according to population size. A table for all hospitals with a sufficient population of cancer decedents, including both rates and confidence limits, is 
available on the Downloads page of our web site: http://www.dartmouthatlas.org/downloads.aspx.
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Hospital Name City Number of deaths 
among cancer patients 
assigned to hospital
Percent of cancer 
patients dying in 
hospital
Percent of cancer 
patients admitted to 
hospital during the last 
month of life
Hospital days per 
cancer patient during 
the last month of life
Percent of cancer 
patients admitted  
to intensive care 
during the last 
month of life
ICU days per cancer 
patient during the last 
month of life
Percent of cancer 
patients receiving life-
sustaining treatment 
during the last month 
of life
Percent of cancer 
patients receiving 
chemotherapy during 
the last two weeks 
of life
Percent of cancer 
patients enrolled in 
hospice during the 
last month of life
Hospice days per 
cancer patient during 
the last month of life
Percent of cancer 
patients enrolled in 
hospice during the 
last three days of life
Hospital Name
Carolinas Medical Center Charlotte, nC 219 36.4 63.2 6.4 33.9 2.5 13.6 4.7 54.1 10.2 Carolinas Medical Center
duke university Hospital durham, nC 348 29.8 53.4 5.1 20.7 0.9 9.1 4.7 57.4 11.4 4.9 duke university Hospital
Pitt County Memorial Hospital Greenville, nC 230 38.9 58.5 4.9 26.3 1.5 9.1 5.5 45.8 9.1 Pitt County Memorial Hospital
north Carolina Baptist Hospital Winston-salem, nC 232 33.5 63.1 6.2 32.1 1.5 14.6 5.4 59.3 10.3 6.4 north Carolina Baptist Hospital
akron General Medical Center akron, oH 189 21.4 67.5 5.3 20.8 0.4 6.7 69.2 8.5 13.0 akron General Medical Center
summa Health system akron, oH 175 26.8 67.7 5.9 29.0 1.4 9.7 63.8 9.2 10.4 summa Health system
university Hospital Cincinnati, oH 102 26.6 69.2 6.0 40.2 2.1 19.3 63.2 8.6 12.4 university Hospital
Cleveland Clinic foundation Cleveland, oH 347 32.4 55.9 6.0 19.0 0.7 11.1 2.9 56.9 10.3 5.0 Cleveland Clinic foundation
MetroHealth Medical Center Cleveland, oH 80 34.4 66.3 4.8 28.7 1.5 63.4 11.4 MetroHealth Medical Center
university Hospitals of Cleveland Cleveland, oH 241 24.2 65.3 4.7 23.0 0.7 10.6 70.6 11.1 14.3 university Hospitals of Cleveland
ohio state university Medical Center Columbus, oH 141 27.0 59.5 5.7 23.4 1.4 13.7 53.0 8.1 ohio state university Medical Center
Western reserve Care system youngstown, oH 128 34.9 62.5 4.7 12.5 0.6 9.3 42.3 7.4 Western reserve Care system
oklahoma university Medical Center oklahoma City, oK 90 30.9 50.8 4.3 22.6 0.9 13.9 52.1 9.8 oklahoma university Medical Center
st. luke’s Hospital Bethlehem, Pa 218 20.3 66.6 6.2 31.8 1.8 9.2 6.3 65.6 9.4 12.2 st. luke’s Hospital
Geisinger Medical Center danville, Pa 128 30.5 65.9 4.9 17.1 0.5 51.6 7.5 10.7 Geisinger Medical Center
Penn state Hershey Medical Center Hershey, Pa 188 36.1 60.2 6.0 37.6 2.3 14.1 7.1 44.1 7.0 6.7 Penn state Hershey Medical Center
fox Chase Cancer Center Philadelphia, Pa 111 28.9 60.7 6.8 30.3 1.7 11.3 63.8 9.7 11.5 fox Chase Cancer Center
Hospital of the university of Pennsylvania Philadelphia, Pa 178 38.3 57.5 5.9 27.7 1.3 14.7 53.0 7.8 8.7 Hospital of the university of Pennsylvania
thomas Jefferson university Hospital Philadelphia, Pa 189 34.7 60.0 6.7 42.4 3.3 12.1 52.4 6.7 10.9 thomas Jefferson university Hospital
allegheny General Hospital Pittsburgh, Pa 124 38.0 71.5 8.4 46.0 4.1 24.8 43.5 6.7 allegheny General Hospital
Mercy Hospital of Pittsburgh Pittsburgh, Pa 81 31.6 63.8 6.7 16.8 1.1 55.2 7.4 14.0 Mercy Hospital of Pittsburgh
uPMC Presbyterian shadyside Pittsburgh, Pa 370 27.7 65.3 6.1 29.3 1.2 11.7 3.9 53.5 7.1 13.1 uPMC Presbyterian shadyside
lankenau Hospital Wynnewood, Pa 97 31.1 70.1 6.1 43.7 3.2 14.5 56.3 8.2 lankenau Hospital
york Hospital york, Pa 216 29.6 65.5 5.6 20.2 0.9 8.2 5.9 47.3 7.0 10.5 york Hospital
rhode island Hospital Providence, ri 165 29.8 62.2 5.9 25.4 1.4 9.8 8.1 58.7 8.6 12.0 rhode island Hospital
MusC Medical Center Charleston, sC 124 24.5 60.6 5.0 28.7 1.8 7.4 65.8 11.8 9.3 MusC Medical Center
Erlanger Medical Center Chattanooga, tn 131 28.8 61.6 6.4 22.3 1.3 7.7 60.2 9.9 Erlanger Medical Center
university of tennessee Medical Center Knoxville, tn 133 36.8 65.6 6.4 26.8 1.0 9.0 8.3 44.7 6.4 university of tennessee Medical Center
Vanderbilt university Medical Center nashville, tn 156 25.2 54.4 4.7 33.5 2.1 11.0 58.0 10.7 7.0 Vanderbilt university Medical Center
university of texas Medical Branch Hospitals Galveston, tX 110 25.0 54.7 4.7 17.4 0.7 63.4 11.2 university of texas Medical Branch Hospitals
university of texas M.d. anderson Cancer Ctr Houston, tX 613 28.8 57.7 5.8 25.8 1.8 6.6 6.7 61.2 10.0 7.2 university of texas M.d. anderson Cancer Ctr
university Medical Center lubbock, tX 80 30.6 62.2 5.9 16.3 1.1 66.7 12.8 university Medical Center
scott and White Memorial Hospital temple, tX 136 21.9 64.4 4.4 15.4 0.5 9.0 61.2 8.5 12.2 scott and White Memorial Hospital
university of utah Hospital salt lake City, ut 125 24.1 58.0 4.2 33.5 1.5 62.1 9.4 10.8 university of utah Hospital
fletcher allen Health Care Burlington, Vt 166 29.8 61.9 5.1 13.8 0.3 10.0 6.6 46.6 6.7 9.8 fletcher allen Health Care
university of Virginia Medical Center Charlottesville, Va 227 30.7 58.3 5.1 25.7 1.2 12.2 4.1 51.3 10.2 university of Virginia Medical Center
VCu Health system richmond, Va 118 31.8 65.6 5.8 25.4 1.6 49.1 8.6 VCu Health system
university of Washington Medical Center seattle, Wa 105 21.3 44.6 4.2 12.2 1.2 57.9 10.2 university of Washington Medical Center
West Virginia university Hospitals Morgantown, WV 102 26.6 59.2 5.7 32.6 2.2 10.7 51.3 9.5 West Virginia university Hospitals
university of Wisconsin Hospital & Clinics Madison, Wi 178 22.5 55.7 4.6 19.6 0.6 6.5 61.1 10.9 6.0 university of Wisconsin Hospital & Clinics
froedtert Memorial lutheran Hospital Milwaukee, Wi 164 19.6 63.2 4.7 18.7 0.5 6.7 66.2 10.8 7.8 froedtert Memorial lutheran Hospital
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